0.04 CHF
(0.98%)
Add to watchlist
Create an alert
Stocks and Shares ISAMolecular Partners AG is a Switzerland-based clinical-stage biotech company developing DARPin (Designed Ankyrin Repeat Proteins) a new class of custom-built protein therapeutics based on natural binding proteins that open a new dimension of multi-functionality and multi-target specificity in drug design. The Company has formed partnerships with leading pharmaceutical companies to advance DARPin therapeutics , and has compounds in various stages of clinical and preclinical development across multiple therapeutic areas.
Company Information
About this company
Key people
Patrick Amstutz
Chief Executive Officer, Executive Director, Member of the Management Board
Alexander Zuercher
Chief Operating Officer, Member of the Management Board
Renate Gloggner
Executive Vice President - People and Community, Member of the Management Board
Michael Tobias Stumpp
Executive Vice President - Projects, Member of the Management Board
Martin Steegmaier
Chief Scientific Officer, Member of the Management Board of Molecular Partners
Philippe Legenne
Member of the Management Board, Chief Medical Officer
William M. Burns
Non-Executive Independent Chairman of the Board
Agnete B. Fredriksen
Non-Executive Independent Director
Dominik Hoechli
Non-Executive Independent Director
Steven H. Holtzman
Non-Executive Independent Director
Sandip S. Kapadia
Non-Executive Independent Director
Click to see more
Key facts
- Shares in issue40.37m
- EPICMOLN
- ISINCH0256379097
- LocationSwitzerland
- SectorHealthcare
- IndustryBiotechnology & Drugs
- Market capCHF 143.94m
- Employees153
- ExchangeSIX Swiss Exchange
- Index
- Website
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.